Study KuS (Klettern und Stimmung - Climbing and Mood) combined boulder and psychotherapy against depressio

Not Applicable

Completed

• Conditions: Mental and Behavioural Disorders; Depression

• Registration Number: ISRCTN12457760
• Lead Sponsor: OH-DO-KWAN Stiftung Ludmilla Pankofer und Carl Wiedmeier

Brief Summary

2019 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/31101097 protocol (added 11/03/2020) 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32164679/ results (added 07/10/2020) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34446114/ (added 10/09/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34702280/ (added 05/09/2023)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-07-26
• Study Completion: 2020-10-01
• Last Update Posted: 18 September 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 133

Inclusion Criteria

Current Inclusion Criteria as of 13/03/2018:
1. Depression, measured by the score of the PHQ-9 (Cut-off = 8)
2. Informed Consent to participate in the study (especially regarding randomised allocation and data acquisition)
3. Possibility to come to the therapy locations

Previous Inclusion Criteria:
1. Depression, measured by the score of the PHQ-9 (Cut-off = 10)
2. Informed Consent to participate in the study (especially regarding randomised allocation and data acquisition)
3. Possibility to come to the therapy locations

Exclusion Criteria

Current exclusion criteria as of 13/03/2018:
1. Acute suicidality
2. Severe psychiatric disorder (psychosis, mania, substance-abuse)
3. Physical contraindication (physical disorders or pregnancy)
4. BMI <17,5 or >40
5. Age < 18 years
6. Actual participation in group psychotherapy
8. Start of psychiatric medication within the last 8 weeks
9. Planned in-Patient stay during therapy

Previous exclusion criteria:
1. Acute suicidality
2. Severe psychiatric disorder (psychosis, mania, substance-abuse)
3. Physical contraindication (physical disorders or pregnancy)
4. BMI <18,5 or >35
5. Age < 18 years
6. Actual participation in group psychotherapy
8. Start of psychiatric medication within the last 8 weeks
9. Planned in-Patient stay during therapy

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Depression is measured using the score of an observer-rating-scale (Montgomery Asberg Rating Scale, MADRS) by computer-assisted telephone interviews (CATI) at baseline, ten weeks, three, six and 12 months